Viva Biotech Holdings Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Profit Before Tax
320.00
-61.00
-533.00
419.00
-399.00
320.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-35.00
34.00
-20.00
-315.00
-82.00
-4.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
368.00
379.00
351.00
66.00
66.00
68.00
Cash Flow from Investing Activities
223.00
1,005.00
-420.00
-1,106.00
-4,356.00
-345.00
Cash Flow from Financing Activities
-697.00
-950.00
-81.00
-701.00
5,977.00
1,117.00
Net Cash Inflow / Outflow
-102.00
395.00
-142.00
-1,816.00
1,578.00
848.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
3.00
-39.00
8.00
-76.00
-108.00
8.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in HKD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Viva Biotech Holdings
Figures in Million
consolidated Cash Flow Results
Change(HKD)
Change(%)
Profit Before Tax
320.713412612799
-168.823410292516
488.00
289.97%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-35.7175860436221
83.5654684371834
-118.00
-142.74%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
368.492988904282
-42.2142553079086
410.00
972.91%
Cash Flow from Investing Activities
223.120256101294
232.523729487334
-9.00
-4.04%
Cash Flow from Financing Activities
-697.731653590693
30.2053920283298
-727.00
-2409.96%
Net Cash Inflow / Outflow
-102.580586187025
225.450253138835
-327.00
-145.50%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
3.53782239809183
4.93538693107998
-1.00
-28.32%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'24
YoY Growth in year ended Dec 2024 is -2.90% vs 7.95% in Dec 2023
Dec'24
Dec'23
Change(%)
Cash Flow from Operating Activities
368.49
379.49
-2.90%






